PA
MUX icon

PharVision Advisers’s McEwen Inc MUX Stock Holding History

PharVision Advisers’s Portfolio MUX Stock Details MUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,999
Closed -$278K – 450
2025
Q4 		$278K Buy
+14,999
New +$279K 0.14% 321
2025
Q3 		– Sell
-16,068
Closed -$154K – 746
2025
Q2 		$154K Buy
+16,068
New +$131K 0.22% 229

Other funds holding MUX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's MUX Position: Q1 2026 in Review

PharVision Advisers sold out of McEwen Inc (MUX) in Q1 2026, closing a stake of 14,999 shares — an estimated $278K sold.

PharVision Advisers first reported a position in MUX in Q2 2025 and held it in 2 quarters. The position peaked at $278K in Q4 2025. 154 funds tracked by Wall St. Rank hold MUX as of Q1 2026.

  • PharVision Advisers reported no remaining McEwen Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,999 McEwen Inc shares in Q1 2026, an estimated $278K.
  • PharVision Advisers first reported a position in McEwen Inc in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's McEwen Inc position peaked at $278K in Q4 2025.
  • 154 funds tracked by Wall St. Rank held McEwen Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.